PharmaGap Inc. Announces Receipt of Notice of Conversion of Convertible Debentures

OTTAWA, Feb. 11 /CNW Telbec/ - PharmaGap Inc. (TSX-V: GAP) ("PharmaGap" or "the Company") today announced that it has received notice from SC Stormont Holdings Inc. ("Stormont"), holder of 98.5 % of the Company's outstanding Convertible Secured Debentures (the "Debentures"), that Stormont intends to exercise the conversion rights in the Debentures to convert to common shares and warrants of the Company on or prior to the February 26, 2009 maturity date.